Optimizing the Ocular Surface Before and After Cataract Surgery

The role of perfluorohexyloctane in dry eye management

1

Dry eye disease is a common challenge for cataract surgery patients, impacting preoperative measurements and visual outcomes.
2

PFHO treatment did not negatively affect refractive outcomes, with 82.6% of patients achieving predicted manifest refraction after therapy.
3

Clinical signs of dry eye improved significantly, with total corneal fluorescein staining decreasing from 5.0 to 1.3 after PFHO therapy.
4

Postoperative best-corrected visual acuity improved, with 92% of patients achieving 20/20 vision or better after continued PFHO treatment.
5

Aggressive treatment of dry eye with PFHO enhances patient comfort and surgical outcomes without compromising refractive accuracy.

1